New listing off like a rocket

Posted 11 August 2022 AM

The pent-up demand for cystic fibrosis drug Trikafta should surprise no one after the intense campaign by advocacy groups, but take up has already exceeded the boldest predictions.

Vertex negotiated hard to get the drug listed for the full patient population and at a higher price than the government wanted to pay, and just when it seemed negotiations had stalled former Health Minister Greg Hunt announced its listing as he headed out of the ministry's door.

To see the whole article, please login